WTDM:XETRA:XETRA-WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc (EUR)

ETF | Others |

Last Closing

USD 42.305

Change

0.00 (0.00)%

Market Cap

USD 0.24B

Volume

264.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.66 (+1.30%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.26%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.31 (+1.16%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.33 (+1.20%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.42%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.70 (+1.16%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.45 (+1.01%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.67 (+1.32%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.34 (+0.25%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.28 (+1.28%)

USD 79.79B

ETFs Containing WTDM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.06% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.06% 85% B 83% B
Trailing 12 Months  
Capital Gain 22.45% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.45% 80% B- 79% B-
Trailing 5 Years  
Capital Gain 103.24% 96% N/A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.24% 96% N/A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.39% 88% B+ 85% B
Dividend Return 14.39% 88% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.63% 57% F 66% D+
Risk Adjusted Return 135.33% 100% F 100% F
Market Capitalization 0.24B 52% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike